ECYT
Endocyte, Inc. Common Stock
ECYT
ECYT
Delisted
ECYT was delisted on the 20th of December, 2018.
139 hedge funds and large institutions have $1.11B invested in Endocyte, Inc. Common Stock in 2018 Q3 according to their latest regulatory filings, with 37 funds opening new positions, 46 increasing their positions, 32 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
139
Holders Change
+25
Holders Change %
+21.93%
% of All Funds
3.18%
Holding in Top 10
8
Holding in Top 10 Change
+5
Holding in Top 10 Change %
+166.67%
% of All Funds
0.18%
New
37
Increased
46
Reduced
32
Closed
12
Calls
$12.6M
Puts
$4.32M
Net Calls
+$8.3M
Net Calls Change
+$10M
Top Buyers
Top Sellers
| 1 |
PHS
PFM Health Sciences
San Francisco,
California
|
$4.16M |
| 2 |
Citadel Advisors
Miami,
Florida
|
$24.2M |
| 3 |
D.E. Shaw & Co
New York
|
$1.33M |
| 4 |
ACA
Avoro Capital Advisors
New York
|
$94.2M |
| 5 |
VMI
VHCP Management II
New York
|
$74.8M |
